Skip to main content
Erschienen in: Acta Diabetologica 5/2012

01.10.2012 | Original Article

Which factors predict glycemic control in children diagnosed with type 1 diabetes before 6.5 years of age?

verfasst von: S. Shalitin, M. Phillip

Erschienen in: Acta Diabetologica | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Predictors of long-term glycemic control and growth patterns in children diagnosed with type 1 diabetes (T1D) before 6.5 years of age were evaluated. One hundred seventy-three children (84 boys) with a mean diabetes duration of 4.9 ± 2.8 years participated in this observational study. Medical charts were reviewed for background, disease- and treatment-related parameters, and growth parameters. Study endpoints were HbA1c value, rates of severe hypoglycemia and diabetic ketoacidosis events, and growth patterns. Mean HbA1c for the total duration of diabetes (HbA1c–TDD) was 7.9 ± 0.8%. Comparison of the study variables between patients with HbA1c–TDD <7.5% (n = 53) or ≥7.5% yielded a significantly shorter duration of diabetes (P = 0.01) and lower rate of diabetic ketoacidosis (P = 0.02) in those with HbA1C–TDD <7.5%, without differences between these groups in age at diabetes onset, insulin regimens, daily glucose measurements, and rate of severe hypoglycemia. Factors significantly predicting achievement of the mean target HbA1c–TDD <7.5% were lower HbA1c at 0.5 years and 1 year after diabetes diagnosis (P = 0.002 and P < 0.001, respectively). Patients followed for at least 5 years (n = 48) showed a significant decrease in height-SDS (P < 0.001) and a significant increase in weight-SDS (P = 0.004) from diabetes diagnosis to the last follow-up visit, without a significant change in weight-SDS from 0.5 years after diagnosis to the last follow-up visit. Our results suggest that in patients with T1D diagnosed during the preschool-age, mean HbA1c level in the first year is a strong predictor of achieving target HbA1c level in the subsequent years, regardless the type of insulin regimen. This “metabolic tracking” emphasizes the importance of achieving early optimal control even in younger children.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373:2027–2033PubMedCrossRef Patterson CC, Dahlquist GG, Gyurus E, Green A, Soltesz G (2009) Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373:2027–2033PubMedCrossRef
2.
Zurück zum Zitat Torres-Avilés F, Carrasco E, Icaza G, Pérez-Bravo F (2010) Clustering of cases of type 1 diabetes in high socioeconomic communes in Santiago de Chile: spatio-temporal and geographical analysis. Acta Diabetol 47(3):251–257PubMedCrossRef Torres-Avilés F, Carrasco E, Icaza G, Pérez-Bravo F (2010) Clustering of cases of type 1 diabetes in high socioeconomic communes in Santiago de Chile: spatio-temporal and geographical analysis. Acta Diabetol 47(3):251–257PubMedCrossRef
3.
Zurück zum Zitat Jarosz-Chobot P, Deja G, Polanska J (2010) Epidemiology of type 1 diabetes among Silesian children aged 0–14 years, 1989–2005. Acta Diabetol 47(1):29–33PubMedCrossRef Jarosz-Chobot P, Deja G, Polanska J (2010) Epidemiology of type 1 diabetes among Silesian children aged 0–14 years, 1989–2005. Acta Diabetol 47(1):29–33PubMedCrossRef
4.
Zurück zum Zitat Lumey LH (2000) Variation and trends in the incidence of childhood diabetes in Europe: EURODIAB ACE Study Group. Lancet 355:873–876CrossRef Lumey LH (2000) Variation and trends in the incidence of childhood diabetes in Europe: EURODIAB ACE Study Group. Lancet 355:873–876CrossRef
5.
Zurück zum Zitat Silverstein J, Malone IJ (2000) Strict glycemic control is necessary but not practical in most children with type 1 diabetes. J Clin Endocrinol Metab 85:2518–2522CrossRef Silverstein J, Malone IJ (2000) Strict glycemic control is necessary but not practical in most children with type 1 diabetes. J Clin Endocrinol Metab 85:2518–2522CrossRef
6.
Zurück zum Zitat Ryan CM, Becker DJ (1999) Hypoglycemia in children with type 1 diabetes mellitus: risk factors, cognitive function, and management. Endocrinol Metab Clin North Am 28:883–900PubMedCrossRef Ryan CM, Becker DJ (1999) Hypoglycemia in children with type 1 diabetes mellitus: risk factors, cognitive function, and management. Endocrinol Metab Clin North Am 28:883–900PubMedCrossRef
7.
Zurück zum Zitat Svensson M, Eriksson JW, Dahlquist G (2004) Early glycemic control, age at onset, and development of microvascular complications in childhood- onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care 27:955–962PubMedCrossRef Svensson M, Eriksson JW, Dahlquist G (2004) Early glycemic control, age at onset, and development of microvascular complications in childhood- onset type 1 diabetes: a population-based study in northern Sweden. Diabetes Care 27:955–962PubMedCrossRef
8.
Zurück zum Zitat Diabetes Control and Complications Trial Research Group (1993) The effect of intensive insulin treatment of diabetes on the development and progression of long term complications on insulin dependent diabetes mellitus. N Engl J Med 329:977–985CrossRef Diabetes Control and Complications Trial Research Group (1993) The effect of intensive insulin treatment of diabetes on the development and progression of long term complications on insulin dependent diabetes mellitus. N Engl J Med 329:977–985CrossRef
9.
Zurück zum Zitat Du Caju MVL, Rooman RP, De Beek LO (1995) Longitudinal data on growth and final height in diabetic children. Pediatr Res 38:607–611PubMedCrossRef Du Caju MVL, Rooman RP, De Beek LO (1995) Longitudinal data on growth and final height in diabetic children. Pediatr Res 38:607–611PubMedCrossRef
10.
Zurück zum Zitat Rudolf MCJ, Shewin RS, Markowitz R, Bates SE, Genel M, Hochstadt J, Tamborlane WV (1982) Effect of intensive insulin treatment on linear growth in the young diabetic patient. J Pediatr 101:333–339PubMedCrossRef Rudolf MCJ, Shewin RS, Markowitz R, Bates SE, Genel M, Hochstadt J, Tamborlane WV (1982) Effect of intensive insulin treatment on linear growth in the young diabetic patient. J Pediatr 101:333–339PubMedCrossRef
11.
Zurück zum Zitat Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) CDC growth charts for the United States: methods and development. Vital Health Stat 11 246:1–190PubMed Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) CDC growth charts for the United States: methods and development. Vital Health Stat 11 246:1–190PubMed
12.
Zurück zum Zitat Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ (2007) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 8:408–418PubMedCrossRef Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ (2007) Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 8:408–418PubMedCrossRef
13.
Zurück zum Zitat Dixon WJ (1993) BMDP statistical software. University of California Press, Berkeley Dixon WJ (1993) BMDP statistical software. University of California Press, Berkeley
14.
Zurück zum Zitat Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O, Ser N, Bougnères PF, Gillet P, Soskin S, Garandeau P, Stuckens C, Le luyer B, Jos J, Bony-Trifunovic H, Bertrand AM, Leturcq F, Lafuma A (1998) Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. Diabetes Care 21(7):1146–1153PubMedCrossRef Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O, Ser N, Bougnères PF, Gillet P, Soskin S, Garandeau P, Stuckens C, Le luyer B, Jos J, Bony-Trifunovic H, Bertrand AM, Leturcq F, Lafuma A (1998) Factors associated with glycemic control. A cross-sectional nationwide study in 2,579 French children with type 1 diabetes. Diabetes Care 21(7):1146–1153PubMedCrossRef
15.
Zurück zum Zitat Sulmont V, Souchon P-F, Gouillard-Darnaud C, Fartura A, Salmon-Musial AS, Lambrecht E, Mauran P, Abely M (2010) Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment? J Pediatr 157:103–107PubMedCrossRef Sulmont V, Souchon P-F, Gouillard-Darnaud C, Fartura A, Salmon-Musial AS, Lambrecht E, Mauran P, Abely M (2010) Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment? J Pediatr 157:103–107PubMedCrossRef
16.
Zurück zum Zitat Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlan WV (2004) Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 114:1601–1605PubMedCrossRef Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlan WV (2004) Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 114:1601–1605PubMedCrossRef
17.
Zurück zum Zitat Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N, American Diabetes Association (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186–212PubMedCrossRef Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, Laffel L, Deeb L, Grey M, Anderson B, Holzmeister LA, Clark N, American Diabetes Association (2005) Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 28:186–212PubMedCrossRef
18.
Zurück zum Zitat Haller MJ, Stalvey MS, Silverstein JH (2004) Predictors of control of diabetes: monitoring may be the key. J Pediatr 144:660–661PubMedCrossRef Haller MJ, Stalvey MS, Silverstein JH (2004) Predictors of control of diabetes: monitoring may be the key. J Pediatr 144:660–661PubMedCrossRef
19.
Zurück zum Zitat Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LMB (2001) Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 139:197–203PubMedCrossRef Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LMB (2001) Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 139:197–203PubMedCrossRef
20.
Zurück zum Zitat Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M (2010) Predictors of glycaemic control in patients with type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med 27(3):339–347PubMedCrossRef Shalitin S, Gil M, Nimri R, de Vries L, Gavan MY, Phillip M (2010) Predictors of glycaemic control in patients with type 1 diabetes commencing continuous subcutaneous insulin infusion therapy. Diabet Med 27(3):339–347PubMedCrossRef
21.
Zurück zum Zitat Ludvigsson J, Heding LG, Larsson Y, Leander E (1977) C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control. Acta Paediatr Scand 66(2):177–184PubMedCrossRef Ludvigsson J, Heding LG, Larsson Y, Leander E (1977) C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control. Acta Paediatr Scand 66(2):177–184PubMedCrossRef
22.
Zurück zum Zitat Edge JA, James T, Shine B (2010) Persistent individual tracking within overall improvement in HbA1c in a UK paediatric diabetes clinic over 15 years. Diabet Med 27:1284–1288PubMedCrossRef Edge JA, James T, Shine B (2010) Persistent individual tracking within overall improvement in HbA1c in a UK paediatric diabetes clinic over 15 years. Diabet Med 27:1284–1288PubMedCrossRef
23.
Zurück zum Zitat Thompson SJ, Auslander WF, White NH (2001) Comparison of single-mother and two-parent families on metabolic control of children with diabetes. Diabetes Care 24:234–238PubMedCrossRef Thompson SJ, Auslander WF, White NH (2001) Comparison of single-mother and two-parent families on metabolic control of children with diabetes. Diabetes Care 24:234–238PubMedCrossRef
24.
Zurück zum Zitat Doyle EA, Weinzimer SA, Steffen AT, Ahern JAH, Vincent M, Tamborlane WV (2004) A randomized prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 27:1554–1558PubMedCrossRef Doyle EA, Weinzimer SA, Steffen AT, Ahern JAH, Vincent M, Tamborlane WV (2004) A randomized prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 27:1554–1558PubMedCrossRef
25.
Zurück zum Zitat Nabhan ZM, Kreher NC, Greene DM, Eugster EA, Kronenberger W, DiMeglio LA (2009) A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes. Pediatr Diabetes 10(3):202–208PubMedCrossRef Nabhan ZM, Kreher NC, Greene DM, Eugster EA, Kronenberger W, DiMeglio LA (2009) A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes. Pediatr Diabetes 10(3):202–208PubMedCrossRef
26.
Zurück zum Zitat DiMeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA (2004) A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 145(3):380–384PubMedCrossRef DiMeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA (2004) A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 145(3):380–384PubMedCrossRef
27.
Zurück zum Zitat Berghaeuser MA, Kapellen T, Heidtmann B, Haberland H, Klinkert C, Holl RW, German Working Group for Insulin Pump Treatment in Paediatric Patients (2008) Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes 9(6):590–595PubMedCrossRef Berghaeuser MA, Kapellen T, Heidtmann B, Haberland H, Klinkert C, Holl RW, German Working Group for Insulin Pump Treatment in Paediatric Patients (2008) Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes 9(6):590–595PubMedCrossRef
28.
Zurück zum Zitat Shehadeh N, Battelino T, Galatzer A, Naveh T, Hadash A, de Vries L, Phillip M (2004) Insulin pump therapy for 1–6 year old children with type 1 diabetes. Isr Med Assoc J 6:284–286PubMed Shehadeh N, Battelino T, Galatzer A, Naveh T, Hadash A, de Vries L, Phillip M (2004) Insulin pump therapy for 1–6 year old children with type 1 diabetes. Isr Med Assoc J 6:284–286PubMed
29.
Zurück zum Zitat Jeha GS, Karaviti LP, Anderson B, Smith EO, Donaldson S, McGirk TS, Haymond MW (2005) Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 7(6):876–884PubMedCrossRef Jeha GS, Karaviti LP, Anderson B, Smith EO, Donaldson S, McGirk TS, Haymond MW (2005) Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther 7(6):876–884PubMedCrossRef
30.
Zurück zum Zitat Swift PGF, Skinner TC, De Beaufort CE, Cameron FJ, Aman J, Aanstoot HJ, Castaño L, Chiarelli F, Daneman D, Danne T, Dorchy H, Hoey H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njølstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M, Ackermann RW, Skovlund SE, Hvidoere Study Group on Childhood Diabetes (2010) Target setting in intensive insulin management is associated with metabolic control: the Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005. Pediatr Diabetes 11(4):271–278PubMedCrossRef Swift PGF, Skinner TC, De Beaufort CE, Cameron FJ, Aman J, Aanstoot HJ, Castaño L, Chiarelli F, Daneman D, Danne T, Dorchy H, Hoey H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njølstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M, Ackermann RW, Skovlund SE, Hvidoere Study Group on Childhood Diabetes (2010) Target setting in intensive insulin management is associated with metabolic control: the Hvidoere Childhood Diabetes Study Group Centre Differences Study 2005. Pediatr Diabetes 11(4):271–278PubMedCrossRef
31.
Zurück zum Zitat Luna R, Fluiters E, Rodriguez I, Garcia-Mayor RV (2004) Growth in type 1 diabetic children. Diabet Med 21(9):1054–1056PubMedCrossRef Luna R, Fluiters E, Rodriguez I, Garcia-Mayor RV (2004) Growth in type 1 diabetic children. Diabet Med 21(9):1054–1056PubMedCrossRef
32.
Zurück zum Zitat Choudhury S, Stutchfield P (2000) Linear growth and weight gain in diabetic children a cross-sectional and longitudinal evaluation. J Pediatr Endocrinol Metab 13:537–544PubMedCrossRef Choudhury S, Stutchfield P (2000) Linear growth and weight gain in diabetic children a cross-sectional and longitudinal evaluation. J Pediatr Endocrinol Metab 13:537–544PubMedCrossRef
33.
Zurück zum Zitat Cameron FJ, Skinner TC, de Beaufort CE, Hoey H, Swift PG, Aanstoot H, Aman J, Martul P, Chiarelli F, Daneman D, Danne T, Dorchy H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njølstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M, Ackermann RW, Skovlund SE, Hvidoere Study Group on Childhood Diabetes (2008) Are family factors universally related to metabolic outcome in adolescents with type 1 diabetes? Diabet Med 25(4):463–468PubMedCrossRef Cameron FJ, Skinner TC, de Beaufort CE, Hoey H, Swift PG, Aanstoot H, Aman J, Martul P, Chiarelli F, Daneman D, Danne T, Dorchy H, Kaprio EA, Kaufman F, Kocova M, Mortensen HB, Njølstad PR, Phillip M, Robertson KJ, Schoenle EJ, Urakami T, Vanelli M, Ackermann RW, Skovlund SE, Hvidoere Study Group on Childhood Diabetes (2008) Are family factors universally related to metabolic outcome in adolescents with type 1 diabetes? Diabet Med 25(4):463–468PubMedCrossRef
34.
Zurück zum Zitat Urbach SL, LaFranchi S, Lambert L, Lapidus JA, Daneman D, Becker T (2005) Predictors of glucose control in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 6:69–74PubMedCrossRef Urbach SL, LaFranchi S, Lambert L, Lapidus JA, Daneman D, Becker T (2005) Predictors of glucose control in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 6:69–74PubMedCrossRef
Metadaten
Titel
Which factors predict glycemic control in children diagnosed with type 1 diabetes before 6.5 years of age?
verfasst von
S. Shalitin
M. Phillip
Publikationsdatum
01.10.2012
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 5/2012
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-011-0321-x

Weitere Artikel der Ausgabe 5/2012

Acta Diabetologica 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.